Tag: Bria-OTS™
August 12, 2019
BriaCell Appoints Richard J. Berman to Board of Directors
BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSXV:BCT, OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast... July 23, 2019
BriaCell Announces $350,000 Equity Investment by Board of Directors
BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSXV:BCT, OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast... May 28, 2019
BriaCell’s Breakthrough Cancer Treatment Technology Featured in BNN Bloomberg
BriaCell Therapeutics (TSXV:BCT) (OTC:BCTXF) was recently featured in a sponsored article published in BNN Bloomberg. May 28, 2019
BriaCell’s Novel Technology and Clinical Data Published at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSXV:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast... May 24, 2019
BriaCell’s Immunotherapy Technology Featured in The Financial Post
BriaCell Therapeutics (TSXV:BCT) (OTCQB:BCTXF) has been featured in a paid advertisement published in The Financial Post. May 13, 2019
BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders
BriaCell Therapeutics Corp. (TSX:BCT, OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today announced that... April 23, 2019